Apex Biotechnology Corp. | Mutual Funds
Mutual Funds that own Apex Biotechnology Corp.
Fidelity Low Priced Stock Fund
1,400,000
1.4%
0
0%
04/30/2018
DFA Emerging Markets Core Equity Portfolio
806,625
0.81%
0
0%
04/30/2018
DFA Emerging Markets Small Cap Series
763,483
0.77%
35,000
0.01%
01/31/2018
Fidelity Northstar Fund
650,000
0.65%
0
0.01%
07/31/2018
RAM (Lux) Systematic Funds - Emerging Markets Equities
151,867
0.15%
-77,000
0.01%
06/30/2017
124,777
0.13%
855
0.01%
07/31/2018
Dimensional Funds Plc - Emerging Markets Value Fund
70,629
0.07%
-19,159
0%
11/30/2017
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
39,502
0.04%
0
0%
12/31/2017
DFA Emerging Markets Social Core Equity Portfolio
35,477
0.04%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
32,000
0.03%
0
0%
04/30/2018
| Address |
7 Li-Hsin Road V
Hsinchu
Taiwan
|
|
Employees
|
- |
| Website |
http://www.apexbio.com |
| Updated |
07/08/2019 |
| Apex Biotechnology Corp. is engaged in researching, developing, manufacturing and selling biotechnological products. The firm's other activities include exporting and importing related products and components. Its products include blood glucose monitoring system, uric acid monitoring system, cholesterol monitoring system, blood hemoglobin monitoring system, pesticide residue detection system, read-time PCR HBV/HCV test kits, and lactate monitoring system. |
